Therapeutic use of VEGF-C and CCBE1

Kari  Alitalo; Michael Jeltsch; Andrey Anisimov

Therapeutic use of VEGF-C and CCBE1

Kari Alitalo, Michael Jeltsch, Andrey Anisimov

Tutkimusohjelmayksikkö

Tutkimustuotos: Patentti

Abstrakti

The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.

Alkuperäiskieli	englanti
Julkaisuvuosi	19 helmikuuta 2015
Tila	Julkaistu - 19 helmikuuta 2015
OKM-julkaisutyyppi	H1 Myönnetyt patentit

Tieteenalat

3111 Biolääketieteet

Pääsy asiakirjaan

Siteeraa tätä

@misc{30eb885ad8db4ddda2b3efce05d8e270,

title = "Therapeutic use of VEGF-C and CCBE1",

abstract = "The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.",

keywords = "3111 Biomedicine",

author = "Kari Alitalo and Michael Jeltsch and Andrey Anisimov",

year = "2015",

month = feb,

day = "19",

language = "English",

publisher = "WIPO",

address = "Switzerland",

type = "Patent",

note = "WO2015/022447",

}

TY - PAT

T1 - Therapeutic use of VEGF-C and CCBE1

AU - Alitalo, Kari

AU - Jeltsch, Michael

AU - Anisimov, Andrey

PY - 2015/2/19

Y1 - 2015/2/19

N2 - The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.

AB - The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.

KW - 3111 Biomedicine

UR - https://worldwide.espacenet.com/publicationDetails/biblio?CC=WO&NR=2015022447&KC=&FT=E&locale=en_EP#

M3 - Patent

M1 - WO2015/022447

Y2 - 2015/02/15

PB - WIPO

ER -